Xencor, Inc.
US ˙ NasdaqGM ˙ US98401F1057

Introduksjon

Denne siden gir en grundig analyse av den kjente historikken for insidernes handelsaktiviteter for Todd E Simpson. Insidere er ledere, direktører eller betydelige investorer i et selskap. Det er ulovlig for insidere å gjøre handler i deres selskaper basert på spesifikke, ikke-offentlig informasjon. Dette betyr ikke at det er ulovlig for dem å gjøre noen handler i deres egne selskaper. Imidlertid må de rapportere alle handler til SEC via et skjema 4. Til tross for disse begrensningene, antyder akademisk forskning at insidere - generelt sett - har en tendens til å overgå markedet i sine egne selskaper.

Gjennomsnittlig handelslønnsomhet

Den gjennomsnittlige handelslønnsomheten er den gjennomsnittlige avkastningen av alle åpne markedskjøp gjort av insideren de siste tre årene. For å beregne dette, undersøker vi hvert eneste åpne marked, uplanlagte kjøp som er gjort av insideren, men dette inkluderer ikke alle handler som ble markert som en del av en 10b5-1 handelsplan. Vi beregner deretter gjennomsnittlig ytelse av disse handlene over 3, 6 og 12 måneder, gjennomsnittlig hver av disse varighetene for å generere en endelig ytelsesmåling for hver handel. Til slutt,

Dersom lønnsomheten for denne interne handelen er "N/A", har enten den interne personen ikke gjort noen åpen-markeds kjøp de siste tre årene, eller så er handlene for nylig til å beregne en pålitelig prestasjonsmåler.

Oppdateringsfrekvens: Daglig

Se listen over de mest lønnsomme insidetraderne.

Selskaper med rapporterte insiderposisjoner

SEC-arkiveringene indikerer at Todd E Simpson har rapporterte beholdninger av handler i følgende selskaper:

Verdipapir Navn Siste rapporterte høydepunkter
US:XNCR / Xencor, Inc. Director 13 686
US:SGEN / Seagen Inc Chief Financial Officer 0
US:NLTX / Neoleukin Therapeutics, Inc. Director 25 000
Hvordan tolke diagrammene

De følgende diagrammene viser aksjens ytelse etter hver åpen markedstransaksjon som ikke var planlagt, utført av Todd E Simpson. Ikke-planlagte handler er handler som ikke ble gjort som en del av en 10b5-1 handelsplan. Aksjeytelsen er kartlagt som kumulativ prosentendring i aksjekursen. For eksempel, hvis en innsidehandel ble gjort 1. januar 2019, vil diagrammet vise daglig prosentendring for verdipapiret til dagens dato. Dersom aksjeprisen går fra $10 til $15 i løpet av denne tiden, vil den kumulative prosentendringen i aksjeprisen være 50%. En endring i prisen fra $10 til $20 vil være 100%, og en endring i prisen fra $10 til $5 vil være - 50%.

Til syvende og sist er målet vårt å avgjøre hvor tett insidernes handler korrelerer med overavkastninger (positiv eller negativ) i aksjekursen for å se om insidere timer sine handler for å tjene på intern informasjon. Se for deg en situasjon der en insider gjør dette. I denne situasjonen, forventer vi enten (a) positive avkastninger etter kjøp, eller (b) negative avkastninger etter salg. I tilfelle (a) KJØP-diagrammet ville vise en serie av oppadgående kurver, som indikerer positive avkastninger etter hver kjøpstransaksjon. I tilfelle (b) ville SALG-diagrammet vise en serie av nedadgående kurver, som indikerer negative avkastninger etter hver salgstransaksjon.

Imidlertid er dette alene ikke nok til å dra konklusjoner. Hvis, for eksempel, aksjeprisen for selskapet steg jevnt over mange år uten å følge en syklisk trend, ville vi forventet at alle postkjøpsdiagrammer skal ha en stigende trend. På samme måte vil ikke-sykliske nedganger over mange år resultere i nedadgående trend i post-trade diagrammer. Ingen av disse diagrammene ville antyde aktiviteter som insidertrening.

Den sterkeste indikatoren ville vært en situasjon der aksjekursen var ekstremt syklisk, og det var både positive signaler i KJØPSdiagrammet og negative plot i SALGSdiagrammet. Denne situasjonen ville vært sterkt antydende om en insider som timet handler til sin økonomiske fordel.

Internkjøp XNCR / Xencor, Inc. - Analyse av kortsiktig fortjeneste

I denne seksjonen analyserer vi lønnsomheten av hvert uplanlagt, åpen-marked internsalg som er gjort i XNCR / Xencor, Inc.. Denne analysen hjelper til å forstå om den interne personen regelmessig genererer unormale avkastninger, og er verdt å følge. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.

Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.

Handelsdato Ticker Innsider Rapporterte
aksjer
Rapportert
pris
Justerte
aksjer
Justert
pris
Kostpris Dager til
maks
Pris ved
maks
Maks
fortjeneste ($)
Maks fortjeneste (%)
Det er ingen kjente uplanlagte handler på det åpne markedet for denne insideren og verdipapirkombinasjonen.

Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.

XNCR / Xencor, Inc. Insider Trades
Internhandel XNCR / Xencor, Inc. - Analyse av kortsiktig tap

I denne seksjonen analyserer vi unngåelsen av kortsiktig tap for hvert uplanlagt, åpen-marked internsalg som er gjort i XNCR / Xencor, Inc.. Et jevnt mønster av tap unngåelse kan antyde at fremtidige salgstransaksjoner kan forutsi nedgang i pris. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.

Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.

Handelsdato Ticker Innsider Rapporterte
aksjer
Rapportert
pris
Justerte
aksjer
Justert
pris
Kostpris Dager til
min
Pris ved
min
Maks tap
unngått ($)
Maks tap
unngått (%)
Det er ingen kjente uplanlagte handler på det åpne markedet for denne insideren og verdipapirkombinasjonen.

Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.

XNCR / Xencor, Inc. Insider Trades
Innsidernes handelshistorikk

Tabellen viser den komplette listen over innsidehandler gjort av Todd E Simpson som avslørt til Securies Exchange Comission (SEC).

Fildato Transaksjonsdato Skjema Ticker Verdipapir Kode 10b5-1 Aksjer Gjenværende aksjer Prosent
endring
Aksje
pris
Transaksjons
verdi
Gjenværende
verdi
2025-06-16 2025-06-12 4 XNCR Xencor Inc
Common Stock
A - Award 13 686 13 686
2023-12-15 2023-12-14 4 SGEN Seagen Inc.
Common Stock
D - Sale to Issuer −93 292 0 −100,00 229,00 −21 363 868
2023-09-22 2023-09-21 4 SGEN Seagen Inc.
Common Stock
S - Sale X −80 128 723 −0,06 206,50 −16 520 26 581 300
2023-09-01 2023-08-31 4 SGEN Seagen Inc.
Common Stock
S - Sale X −2 122 128 803 −1,62 206,97 −439 182 26 657 829
2023-08-30 2023-08-29 4 SGEN Seagen Inc.
Common Stock
S - Sale X −485 130 925 −0,37 206,00 −99 910 26 970 550
2023-08-30 2023-08-28 4 SGEN Seagen Inc.
Common Stock
A - Award 1 225 131 410 0,94
2023-08-17 2023-08-16 4 SGEN Seagen Inc.
Common Stock
D - Sale to Issuer X −1 540 130 185 −1,17 193,87 −298 558 25 238 823
2023-08-17 2023-08-16 4 SGEN Seagen Inc.
Common Stock
D - Sale to Issuer X −861 131 725 −0,65 193,87 −166 921 25 537 381
2023-08-17 2023-08-16 4 SGEN Seagen Inc.
Common Stock
D - Sale to Issuer X −1 106 132 586 −0,83 193,87 −214 419 25 704 302
2023-08-17 2023-08-15 4 SGEN Seagen Inc.
Common Stock
A - Award 14 746 133 692 12,40
2023-04-12 2023-04-10 4 SGEN Seagen Inc.
Common Stock
S - Sale X −40 364 118 946 −25,34 204,74 −8 264 125 24 353 004
2023-04-12 2023-04-10 4 SGEN Seagen Inc.
Common Stock
M - Exercise 40 364 159 310 33,93 46,37 1 871 679 7 387 205
2023-04-12 2023-04-10 4 SGEN Seagen Inc.
Common Stock
S - Sale X −14 980 118 946 −11,19 204,14 −3 058 017 24 281 636
2023-04-12 2023-04-10 4 SGEN Seagen Inc.
Common Stock
M - Exercise 14 980 133 926 12,59 46,37 694 623 6 210 149
2023-04-07 2023-04-06 4 SGEN Seagen Inc.
Common Stock
S - Sale X −243 118 946 −0,20 205,86 −50 023 24 485 819
2023-04-07 2023-04-05 4 SGEN Seagen Inc.
Common Stock
A - Award 609 119 189 0,51
2023-04-04 2023-04-01 4 SGEN Seagen Inc.
Common Stock
A - Award 1 395 118 580 1,19
2023-03-10 2023-03-09 4 SGEN Seagen Inc.
Common Stock
S - Sale X −6 082 117 185 −4,93 177,37 −1 078 764 20 785 103
2023-03-10 2023-03-09 4 SGEN Seagen Inc.
Common Stock
S - Sale X −26 449 123 267 −17,67 176,71 −4 673 803 21 782 512
2023-03-10 2023-03-09 4 SGEN Seagen Inc.
Common Stock
S - Sale X −10 262 149 716 −6,41 175,89 −1 804 983 26 333 547
2023-03-10 2023-03-09 4 SGEN Seagen Inc.
Common Stock
M - Exercise 42 793 159 978 36,52 45,30 1 938 523 7 247 003
2023-02-28 2023-02-27 4 SGEN Seagen Inc.
Common Stock
S - Sale X −20 000 117 185 −14,58 182,53 −3 650 600 21 389 778
2023-02-21 2023-02-16 4 SGEN Seagen Inc.
Common Stock
S - Sale X −39 946 137 185 −22,55 160,00 −6 391 400 21 949 737
2023-02-21 2023-02-16 4 SGEN Seagen Inc.
Common Stock
M - Exercise 39 946 177 131 29,12 39,15 1 563 886 6 934 679
2022-09-01 2022-08-31 4 SGEN Seagen Inc.
Common Stock
S - Sale X −2 064 137 185 −1,48 154,41 −318 712 21 183 353
2022-09-01 2022-08-31 4 SGEN Seagen Inc.
Common Stock
S - Sale X −2 122 139 249 −1,50 154,41 −327 668 21 502 065
2022-08-17 2022-08-16 4 SGEN Seagen Inc.
Common Stock
S - Sale X −1 106 141 371 −0,78 170,22 −188 258 24 063 479
2022-08-17 2022-08-16 4 SGEN Seagen Inc.
Common Stock
S - Sale X −861 142 477 −0,60 170,22 −146 555 24 251 737
2022-08-17 2022-08-15 4 SGEN Seagen Inc.
Common Stock
A - Award 15 447 143 338 12,08
2022-05-16 2022-05-12 4 NLTX Neoleukin Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 25 000 25 000
2022-04-22 2022-04-20 4 SGEN Seagen Inc.
Common Stock
S - Sale X −567 127 891 −0,44 144,32 −81 829 18 457 050
2021-12-22 2021-12-20 4 SGEN Seagen Inc.
Common Stock
S - Sale X −345 128 458 −0,27 149,85 −51 698 19 249 431
2021-11-05 2021-11-04 4 SGEN Seagen Inc.
Incentive Stock Option (right to buy)
M - Exercise −2 156 0 −100,00
2021-11-05 2021-11-04 4 SGEN Seagen Inc.
Common Stock
M - Exercise 2 156 128 803 1,70 46,37 99 974 5 972 595
2021-11-05 2021-11-03 4 SGEN Seagen Inc.
Non-Qualified Stock Option (right to buy)
M - Exercise −40 232 0 −100,00
2021-11-05 2021-11-03 4 SGEN Seagen Inc.
Common Stock
S - Sale X −40 232 126 647 −24,11 185,00 −7 442 920 23 429 695
2021-11-05 2021-11-03 4 SGEN Seagen Inc.
Common Stock
M - Exercise 40 232 166 879 31,77 44,09 1 773 829 7 357 695
2021-11-02 2021-10-29 4 SGEN Seagen Inc.
Non-Qualified Stock Option (right to buy)
M - Exercise −33 564 0 −100,00
2021-11-02 2021-10-29 4 SGEN Seagen Inc.
Common Stock
S - Sale X −33 564 126 647 −20,95 180,00 −6 041 523 22 796 473
2021-11-02 2021-10-29 4 SGEN Seagen Inc.
Common Stock
M - Exercise 33 564 160 211 26,50 41,04 1 377 467 6 575 059
2021-09-27 2021-09-23 4 SGEN Seagen Inc.
Common Stock
A - Award 201 126 647 0,16 166,22 33 410 21 051 264
2021-09-02 2021-08-31 4 SGEN Seagen Inc.
Common Stock
S - Sale X −2 122 126 446 −1,65 167,52 −355 468 21 181 665
2021-09-02 2021-08-31 4 SGEN Seagen Inc.
Common Stock
S - Sale X −1 865 128 568 −1,43 167,52 −312 416 21 537 133
2021-08-18 2021-08-16 4 SGEN Seagen Inc.
Non-Qualified Stock Option (right to buy)
A - Award 26 427 26 427
2021-08-18 2021-08-16 4 SGEN Seagen Inc.
Incentive Stock Option (right to buy)
A - Award 642 642
2021-08-18 2021-08-16 4 SGEN Seagen Inc.
Common Stock
A - Award 11 095 130 433 9,30
2021-08-18 2021-08-16 4 SGEN Seagen Inc.
Common Stock
S - Sale X −533 119 338 −0,44 154,55 −82 377 18 444 165
2021-05-13 2021-05-11 4 NLTX Neoleukin Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 25 000 25 000
2020-12-18 2020-12-18 4 SGEN Seagen Inc.
Non-Qualified Stock Option (right to buy)
M - Exercise −33 669 0 −100,00
2020-12-18 2020-12-18 4 SGEN Seagen Inc.
Incentive Stock Option (right to buy)
M - Exercise −1 104 0 −100,00
2020-12-18 2020-12-18 4 SGEN Seagen Inc.
Common Stock
M - Exercise 1 104 119 871 0,93 45,30 50 011 5 430 156
2020-12-18 2020-12-18 4 SGEN Seagen Inc.
Common Stock
S - Sale X −33 669 118 767 −22,09 200,00 −6 733 800 23 753 400
2020-12-18 2020-12-18 4 SGEN Seagen Inc.
Common Stock
M - Exercise 33 669 152 436 28,35 26,10 878 761 3 978 580
2020-11-09 2020-11-05 4 SGEN Seagen Inc.
Common Stock
S - Sale −7 509 118 767 −5,95 180,37 −1 354 383 21 421 766
2020-09-02 2020-09-01 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X −469 126 276 −0,37 159,33 −74 726 20 119 555
2020-09-02 2020-09-01 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X −50 126 745 −0,04 157,82 −7 891 20 002 896
2020-09-02 2020-09-01 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X −1 640 126 795 −1,28 156,87 −257 267 19 890 332
2020-09-02 2020-09-01 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X −5 480 128 435 −4,09 155,74 −853 455 20 002 467
2020-09-02 2020-09-01 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X −4 452 133 915 −3,22 155,25 −691 173 20 790 304
2020-09-02 2020-08-31 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X −2 122 138 367 −1,51 155,69 −330 383 21 542 939
2020-09-02 2020-08-31 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X −2 065 140 489 −1,45 155,69 −321 509 21 873 322
2020-08-20 2020-08-18 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X −9 262 142 554 −6,10 158,17 −1 464 959 22 547 595
2020-08-17 2020-08-17 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
A - Award 20 774 20 774
2020-08-17 2020-08-17 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
A - Award 636 636
2020-08-17 2020-08-17 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
A - Award 8 635 151 816 6,03
2020-08-05 2020-08-03 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X −1 905 143 181 −1,31 166,74 −317 640 23 874 000
2020-08-05 2020-08-03 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X −10 375 145 086 −6,67 166,10 −1 723 288 24 098 785
2020-08-05 2020-08-03 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X −7 720 155 461 −4,73 164,96 −1 273 491 25 644 847
2020-07-02 2020-07-01 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X −1 010 163 181 −0,62 171,39 −173 104 27 967 592
2020-07-02 2020-07-01 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X −139 164 191 −0,08 170,18 −23 655 27 942 024
2020-07-02 2020-07-01 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X −5 012 164 330 −2,96 167,66 −840 312 27 551 568
2020-07-02 2020-07-01 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X −4 112 169 342 −2,37 166,99 −686 663 28 278 421
2020-07-02 2020-07-01 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X −1 300 173 454 −0,74 165,86 −215 618 28 769 080
2020-05-07 2020-05-05 4 NLTX Neoleukin Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 25 000 25 000
2020-05-06 2020-05-05 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise −26 867 0 −100,00
2020-05-06 2020-05-05 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
M - Exercise −1 103 0 −100,00
2020-05-06 2020-05-05 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
M - Exercise −2 268 0 −100,00
2020-05-06 2020-05-05 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
M - Exercise −2 436 0 −100,00
2020-05-06 2020-05-05 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
M - Exercise −2 554 0 −100,00
2020-05-06 2020-05-05 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
M - Exercise −3 831 0 −100,00
2020-05-06 2020-05-05 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 3 831 173 888 2,25 26,10 99 989 4 538 477
2020-05-06 2020-05-05 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 2 436 170 057 1,45 41,04 99 973 6 979 139
2020-05-06 2020-05-05 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 2 268 167 621 1,37 44,09 99 996 7 390 410
2020-05-06 2020-05-05 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 2 554 165 353 1,57 39,15 99 989 6 473 570
2020-05-06 2020-05-05 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 1 103 162 799 0,68 45,30 49 966 7 374 795
2020-05-06 2020-05-05 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale −1 200 161 696 −0,74 164,10 −196 920 26 534 314
2020-05-06 2020-05-05 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale −12 167 162 896 −6,95 163,36 −1 987 601 26 610 691
2020-05-06 2020-05-05 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale −13 500 175 063 −7,16 162,45 −2 193 075 28 438 984
2020-05-06 2020-05-05 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 26 867 188 563 16,62 15,46 415 364 2 915 184
2020-05-06 2020-05-04 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise −14 167 0 −100,00
2020-05-06 2020-05-04 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale −14 167 161 696 −8,06 147,00 −2 082 556 23 769 393
2020-05-06 2020-05-04 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 14 167 175 863 8,76 12,00 170 004 2 110 356
2020-04-21 2020-04-21 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
D - Sale to Issuer X −570 161 696 −0,35 139,92 −79 752 22 623 906
2020-04-21 2020-04-19 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
A - Award 1 439 162 266 0,89
2020-04-21 2020-04-19 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
A - Award 2 389 160 827 1,51
2019-12-23 2019-12-19 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
A - Award 871 158 438 0,55
2019-10-15 2019-10-10 4 NLTX Neoleukin Therapeutics, Inc.
Stock Option (right to buy)
A - Award 22 000 22 000
2019-10-02 2019-09-30 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X −15 000 157 567 −8,69 85,00 −1 275 000 13 393 195
2019-09-04 2019-09-03 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X −2 092 172 567 −1,20 70,80 −148 112 12 217 623
2019-09-04 2019-08-30 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
A - Award 49 232 49 232
2019-09-04 2019-08-30 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
A - Award 1 333 1 333
2019-09-04 2019-08-30 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
A - Award 21 288 174 659 13,88
2019-08-30 2019-08-28 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X −5 909 153 371 −3,71 73,21 −432 624 11 228 966
2019-08-22 2019-08-20 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X −12 500 159 280 −7,28 80,00 −1 000 000 12 742 400
2019-04-09 2019-04-05 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X −10 437 171 780 −5,73 78,00 −814 086 13 398 840
2019-04-09 2019-04-05 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X −2 063 182 217 −1,12 78,00 −160 914 14 212 926
2019-03-06 2019-03-04 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X −10 000 184 280 −5,15 75,00 −750 000 13 821 000
2018-09-04 2018-08-30 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
A - Award 47 904 47 904
2018-09-04 2018-08-30 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
A - Award 1 301 1 301
2018-09-04 2018-08-30 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
A - Award 20 715 194 280 11,94
2018-08-29 2018-08-27 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X −5 427 173 565 −3,03 74,23 −402 856 12 884 042
2018-05-09 2018-05-07 4 AQXP AQUINOX PHARMACEUTICALS, INC
Stock Option (Right to Buy)
A - Award 15 000 15 000
2018-03-22 2018-03-20 4 SGEN SEATTLE GENETICS INC /WA
Non-qualified Stock Option (Right to buy)
A - Award 10 526 10 526
2017-11-03 2017-11-01 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X −534 178 992 −0,30 61,59 −32 889 11 024 117
2017-11-03 2017-11-01 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X −38 851 179 526 −17,79 60,90 −2 366 026 10 933 133
2017-09-08 2017-09-06 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale −9 638 218 377 −4,23 52,00 −501 176 11 355 604
2017-08-30 2017-08-28 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X −4 937 228 015 −2,12 47,89 −236 455 10 920 664
2017-08-18 2017-08-17 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
A - Award 55 344 55 344
2017-08-18 2017-08-17 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
A - Award 2 156 2 156
2017-08-18 2017-08-17 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
A - Award 23 000 232 952 10,95
2017-05-10 2017-05-08 4 AQXP AQUINOX PHARMACEUTICALS, INC
Stock Option (Right to Buy)
A - Award 9 000 9 000
2016-08-30 2016-08-27 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
A - Award 42 793 42 793
2016-08-30 2016-08-27 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
A - Award 2 207 2 207
2016-08-30 2016-08-27 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
A - Award 18 000 209 445 9,40
2016-08-22 2016-08-22 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X −3 991 191 445 −2,04 46,59 −185 943 8 919 557
2016-05-11 2016-05-09 4 AQXP AQUINOX PHARMACEUTICALS, INC
Stock Option (Right to Buy)
A - Award 7 500 7 500
2015-10-01 2015-09-29 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
M - Exercise −6 468 0 −100,00
2015-10-01 2015-09-29 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
M - Exercise −8 333 0 −100,00
2015-10-01 2015-09-29 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 8 333 194 675 4,47 12,00 99 996 2 336 100
2015-10-01 2015-09-29 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 6 468 186 342 3,60 15,46 99 995 2 880 847
2015-08-25 2015-08-25 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
A - Award 39 946 39 946
2015-08-25 2015-08-25 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
A - Award 2 554 2 554
2015-08-25 2015-08-25 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
A - Award 17 000 179 874 10,44
2015-08-25 2015-08-20 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X −5 825 162 874 −3,45 42,02 −244 794 6 844 731
2015-03-16 2015-03-12 4 AQXP AQUINOX PHARMACEUTICALS, INC
Stock Option (Right to Buy)
A - Award 5 000 5 000
2014-08-27 2014-08-26 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
A - Award 40 232 40 232
2014-08-27 2014-08-26 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
A - Award 2 268 2 268
2014-08-27 2014-08-26 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
A - Award 17 000 168 699 11,21
2014-08-27 2014-08-24 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale −3 696 151 699 −2,38 43,55 −160 957 6 606 340
2014-03-10 2014-03-06 4 AQXP AQUINOX PHARMACEUTICALS, INC
Stock Option (Right to Buy)
A - Award 8 333 8 333
2014-03-06 3 AQXP AQUINOX PHARMACEUTICALS, INC
No securities are beneficially owned
0
2013-08-30 2013-08-28 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
M - Exercise −8 223 0 −100,00
2013-08-30 2013-08-28 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
M - Exercise −9 017 0 −100,00
2013-08-30 2013-08-28 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
M - Exercise −13 126 0 −100,00
2013-08-30 2013-08-28 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 8 223 155 395 5,59 12,16 99 992 1 889 603
2013-08-30 2013-08-28 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 9 017 147 172 6,53 11,09 99 999 1 632 137
2013-08-30 2013-08-28 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 13 126 138 155 10,50 10,29 135 067 1 421 615
2013-08-30 2013-08-27 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise −12 500 21 169 −37,13
2013-08-30 2013-08-27 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise −12 500 21 169 −37,13
2013-08-30 2013-08-27 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise −4 166 26 867 −13,42
2013-08-30 2013-08-27 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise −2 972 0 −100,00
2013-08-30 2013-08-27 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise −5 625 14 167 −28,42
2013-08-30 2013-08-27 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale −12 500 125 029 −9,09 41,45 −518 095 5 182 152
2013-08-30 2013-08-27 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale −12 500 125 029 −9,09 41,45 −518 095 5 182 152
2013-08-30 2013-08-27 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 12 500 137 529 10,00 26,10 326 250 3 589 507
2013-08-30 2013-08-27 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 12 500 137 529 10,00 26,10 326 250 3 589 507
2013-08-30 2013-08-27 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale −4 166 125 029 −3,22 41,45 −172 671 5 182 152
2013-08-30 2013-08-27 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 4 166 129 195 3,33 15,46 64 406 1 997 355
2013-08-30 2013-08-27 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale −5 625 125 029 −4,31 41,45 −233 143 5 182 152
2013-08-30 2013-08-27 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 5 625 130 654 4,50 12,00 67 500 1 567 848
2013-08-30 2013-08-27 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale −2 972 125 029 −2,32 41,45 −123 182 5 182 152
2013-08-30 2013-08-27 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 2 972 128 001 2,38 12,16 36 140 1 556 492
2013-08-21 2013-08-19 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
A - Award 33 564 33 564 41,04 1 377 467 1 377 467
2013-08-21 2013-08-19 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
A - Award 2 436 2 436 41,04 99 973 99 973
2013-08-21 2013-08-19 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
A - Award 14 400 125 029 13,02
2013-08-21 2013-08-19 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X −3 328 110 629 −2,92 40,91 −136 148 4 525 832
2013-07-15 2013-07-12 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise −29 166 31 033 −48,45
2013-07-15 2013-07-12 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise −18 361 19 792 −48,12
2013-07-15 2013-07-12 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X −29 166 113 957 −20,38 37,94 −1 106 558 4 323 529
2013-07-15 2013-07-12 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 29 166 143 123 25,59 15,46 450 906 2 212 682
2013-07-15 2013-07-12 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X −18 361 113 957 −13,88 37,94 −696 616 4 323 529
2013-07-15 2013-07-12 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 18 361 132 318 16,11 12,00 220 332 1 587 816
2013-07-15 2013-07-11 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise −1 486 2 972 −33,33
2013-07-15 2013-07-11 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise −43 514 38 153 −53,28
2013-07-15 2013-07-11 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X −43 514 113 957 −27,63 36,94 −1 607 407 4 209 572
2013-07-15 2013-07-11 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 43 514 157 471 38,18 12,00 522 168 1 889 652
2013-07-15 2013-07-11 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X −1 486 113 957 −1,29 36,94 −54 893 4 209 572
2013-07-15 2013-07-11 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 1 486 115 443 1,30 12,16 18 070 1 403 787
2013-03-08 2013-03-07 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise −19 494 4 458 −81,39
2013-03-08 2013-03-07 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise −682 0 −100,00
2013-03-08 2013-03-07 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale −19 494 113 957 −14,61 30,70 −598 466 3 498 480
2013-03-08 2013-03-07 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 19 494 133 451 17,11 12,16 237 047 1 622 764
2013-03-08 2013-03-07 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale −682 113 957 −0,59 30,70 −20 937 3 498 480
2013-03-08 2013-03-07 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 682 114 639 0,60 11,09 7 563 1 271 347
2013-03-08 2013-03-07 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale −29 542 113 957 −20,59 30,78 −909 303 3 507 596
2012-11-09 2012-11-08 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
M - Exercise −417 0 −100,00
2012-11-09 2012-11-08 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
M - Exercise −72 320 0 −100,00
2012-11-09 2012-11-08 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 417 143 499 0,29 5,63 2 348 807 899
2012-11-09 2012-11-08 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 72 320 143 082 102,20 5,20 376 064 744 026
2012-09-07 2012-09-06 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise −50 000 23 952 −67,61
2012-09-07 2012-09-06 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X −50 000 70 762 −41,40 28,97 −1 448 500 2 049 975
2012-09-07 2012-09-06 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 50 000 120 762 70,66 12,16 608 000 1 468 466
2012-09-07 2012-09-05 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise −2 825 73 952 −3,68
2012-09-07 2012-09-05 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise −42 175 682 −98,41
2012-09-07 2012-09-05 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X −2 825 70 762 −3,84 27,97 −79 015 1 979 213
2012-09-07 2012-09-05 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 2 825 73 587 3,99 12,16 34 352 894 818
2012-09-07 2012-09-05 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X −42 175 70 762 −37,34 27,97 −1 179 635 1 979 213
2012-09-07 2012-09-05 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 42 175 112 937 59,60 11,09 467 721 1 252 471
2012-08-27 2012-08-27 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise −13 126 42 857 −23,45
2012-08-27 2012-08-27 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise −17 874 0 −100,00
2012-08-27 2012-08-27 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X −13 126 70 762 −15,65 26,97 −354 008 1 908 451
2012-08-27 2012-08-27 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 13 126 83 888 18,55 11,09 145 567 930 318
2012-08-27 2012-08-27 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X −17 874 70 762 −20,17 26,97 −482 062 1 908 451
2012-08-27 2012-08-27 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 17 874 88 636 25,26 10,29 183 923 912 064
2012-08-27 2012-08-24 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise −14 000 17 874 −43,92
2012-08-27 2012-08-24 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X −14 000 70 762 −16,52 26,97 −377 580 1 908 451
2012-08-27 2012-08-24 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 14 000 84 762 19,78 10,29 144 060 872 201
2012-08-22 2012-08-20 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
A - Award 46 169 46 169 26,10 1 205 011 1 205 011
2012-08-22 2012-08-20 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
A - Award 3 831 3 831 26,10 99 989 99 989
2012-08-22 2012-08-20 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
A - Award 20 000 70 762 39,40
2012-08-20 2012-08-16 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise −40 000 31 874 −55,65
2012-08-20 2012-08-16 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X −40 000 50 762 −44,07 25,97 −1 038 800 1 318 289
2012-08-20 2012-08-16 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 40 000 90 762 78,80 10,29 411 600 933 941
2012-06-14 2012-06-14 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise −19 583 0 −100,00
2012-06-14 2012-06-14 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise −30 417 0 −100,00
2012-06-14 2012-06-14 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X −19 583 50 762 −27,84 24,97 −488 988 1 267 527
2012-06-14 2012-06-14 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 19 583 70 345 38,58 5,63 110 252 396 042
2012-06-14 2012-06-14 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X −30 417 50 762 −37,47 24,97 −759 512 1 267 527
2012-06-14 2012-06-14 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 30 417 81 179 59,92 5,20 158 168 422 131
2012-06-14 2012-06-12 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise −45 000 30 417 −59,67
2012-06-14 2012-06-12 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X −45 000 50 762 −46,99 23,97 −1 078 785 1 216 917
2012-06-14 2012-06-12 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 45 000 95 762 88,65 5,20 234 000 497 962
2012-06-08 2012-06-08 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise −35 000 75 417 −31,70
2012-06-08 2012-06-08 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X −35 000 50 762 −40,81 22,97 −803 950 1 166 003
2012-06-08 2012-06-08 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 35 000 85 762 68,95 5,20 182 000 445 962
2006-02-01 2006-01-31 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
A - Award 19 583 19 583 5,63 110 252 110 252
2006-02-01 2006-01-31 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
A - Award 417 417 5,63 2 348 2 348
P
Åpent marked eller private kjøp av ikke-derivat eller derivat sikkerhet.
S
Åpent marked eller private kjøp av ikke-derivat eller derivat sikkerhet.
A
Bevilgning, tildeling eller andre oppkjøp av verdipapirer fra selskapet (slik som en opsjon)
C
Konvertering av derivat
D
Salg eller overføring av verdipapirer tilbake til selskapet
F
Betaling av utøvelseskurs eller skatteplikt ved å bruke deler av verdipapirer mottat fra selskapet
G
Gave av verdipapirer fra eller til insidere
K
Aksjebytting og lignende sikringsavtaler
M
Øvelse eller konvertering av derivatverdipapir mottatt fra selskapet (for eksempel en opsjon)
V
En transaksjon frivilig rapportert på Skjema 4
J
Annet (med en fotnote som beskriver transaksjonen)